US Patent 8029782 Therapeutic ribonucleases
Patent 8029782 was granted and assigned to Quintessence Biosciences on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+124 characters)
Article
Patent abstract
The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
John Kink0
Laura Strong0
Tony Klink0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08029782 Therapeutic ribonucleases US Patent 8029782 Therapeutic ribonucleases
Infobox
Patent Number
08029782
Patent Number
8029782
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08029782 Therapeutic ribonucleases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08029782
Date of patent
October 4, 2011
Patent application number
12572016
Date Filed
October 1, 2009
Patent primary examiner
Find more entities like US Patent 8029782 Therapeutic ribonucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.